Rep. Vern Buchanan

Maddy summaryThe Strengthening Innovation in Medicare and Medicaid Act (HR 6732) establishes new rules for how the Center for Medicare and Medicaid Innovation (CMI) tests healthcare payment and service delivery models. It limits Phase 1 model testing to 5 years and 500,000 beneficiaries or 10% of applicable individuals, caps new Phase 1 models at six per fiscal year, and requires continuous monitoring of impacts on beneficiaries' access to care and health outcomes. The bill mandates public input through 45-day comment periods before model implementation, hardship waivers for providers facing economic challenges, and special consideration for rural and underserved populations. These provisions aim to balance healthcare innovation with patient protection by requiring ongoing evaluation of models' effects on quality of care, health disparities, and access to services.

Maddy summaryThis bill expands Medicare coverage to include additional FDA-approved lung cancer screening tests beyond the current standard. It allows the Medicare program to cover new preventive screening tests for eligible beneficiaries, determined by the Secretary, with frequency and payment limits set by Medicare. The key mechanism updates Medicare's coverage rules to permit these new tests using the existing national coverage determination process, without requiring additional regulatory steps. This change directly affects Medicare beneficiaries who qualify for lung cancer screening, potentially increasing access to newer, evidence-based screening options. The bill applies to Part B Medicare coverage for screenings provided on or after its effective date.

Maddy summaryHR 6539, the Mongolia Third Neighbor Trade Act, would provide duty-free access to the U.S. market for certain Mongolian cashmere and textile products meeting specific criteria. It directly affects Mongolian exporters of cashmere apparel and textiles, requiring products to contain at least 23% cashmere by weight or 51% value, be wholly manufactured in Mongolia, and comply with U.S. environmental standards. The bill aims to boost trade by supporting Mongolia’s cashmere industry - which employs many women and faces challenges like livestock losses from climate disasters - and reduce reliance on Chinese processing. It includes verification requirements to prevent transshipment and expires in 2029.

Maddy summaryThis bill adds Ecuador to the list of countries eligible for trade benefits under the Caribbean Basin Economic Recovery Act (CBERA), specifically designating it as a "CBTPA beneficiary country" for preferential tariff treatment. It requires the President to issue a formal proclamation designating Ecuador as such within 90 days of the bill's enactment. The change would allow Ecuadorian goods to enter the U.S. with reduced or eliminated tariffs under the CBERA framework, directly affecting Ecuador's exporters and U.S. importers of Ecuadorian products. This is a procedural adjustment to existing trade law, not a new policy.

Maddy summaryThis bill amends customs fee rules to allow U.S. Customs and Border Protection (CBP) to adjust merchandise processing fees to cover capital costs like equipment upgrades and facility construction/maintenance at sea ports of entry. It requires CBP to submit annual reports detailing how fee proceeds are used for port infrastructure and outlining remaining capital needs. The bill also prohibits CBP from requiring sea ports to provide administrative, training, or recreational facilities for CBP operations. These provisions aim to improve CBP's funding transparency and infrastructure planning at border ports.

Maddy summaryThis bill, HR 5796, prohibits the Department of Health and Human Services from implementing a proposed rule requiring minimum staffing levels in nursing homes. It creates an advisory panel of 15 members - including rural nursing home staff and experts - to study workforce shortages and report on access barriers for seniors, especially in rural areas. The panel must submit an initial report within 60 days, analyzing staffing challenges and recommending solutions to strengthen the nursing home workforce. These provisions directly aim to prevent nursing home closures (like the 129 that occurred in 2022) that threaten rural seniors’ access to care.

Maddy summaryThis bill would allow Medicare Advantage plans to offer more supplemental benefits to certain high-need enrollees starting in 2025. It defines "specified enrollee" to include people with life-threatening chronic conditions requiring intensive care coordination, low-income beneficiaries, or those facing significant social/socioeconomic risks. The change modifies Medicare Advantage rules to expand eligibility for these supplemental benefits beyond current categories. The law directly affects Medicare Advantage enrollees meeting these new criteria, not the general Medicare population.

Maddy summaryThe Maintaining Investments in New Innovation Act (HR 5547) extends the exclusivity period for certain advanced drugs from 7 to 11 years. It defines an "advanced drug product" as a drug using genetically targeted technology to change how genes work, such as drugs that suppress or activate gene function. The bill amends the Social Security Act to update the definition of "qualifying single source drug" to include these advanced therapies with the longer exclusivity period. This change directly affects drug manufacturers developing such advanced therapies and influences Medicare's drug coverage rules by delaying generic competition for these specific treatments.

Maddy summaryHR 5388, the Supporting Innovation for Seniors Act, allows Medicare Advantage (MA) plans to cover certain new medical technologies and devices starting in 2025. Specifically, it permits MA plans to provide supplemental benefits for medical devices with coverage determinations for different uses than standard Medicare coverage, or technologies that don’t fit into existing benefit categories. The bill lets the Medicare administrator waive standard uniformity rules for these specific supplemental benefits. This directly affects seniors enrolled in Medicare Advantage plans who may gain access to newer health technologies not previously covered under their plan. The change modifies existing Medicare rules without altering core coverage for most beneficiaries.

Maddy summaryThis bill requires Medicare to improve transparency in its national coverage decision process for medical treatments and devices. It mandates that Medicare (through the Secretary of Health and Human Services) must determine within 30 days if a submission is a complete request for a coverage decision, and if not, provide specific feedback on missing information. Complete requests must be posted publicly on a government website within two business days, and annual reports must include the time between submission and the point when the request was deemed complete. This directly affects healthcare providers, pharmaceutical companies, and medical device manufacturers seeking Medicare coverage for new treatments.